Day 1Tuesday, March 10, 2026 - ET (Eastern Time, GMT-05:00)

Join industry leaders for an insightful examination of the current global life science landscape, with a special focus on the United States' competitive position. This panel brings together experienced life science executives to provide a comprehensive view of funding trends and strategic opportunities

• Who is stepping up to fill gaps in early-stage funding, and what new investment models are emerging?
• Which life science companies and therapeutic areas are attracting investor capital in today's market?
• Practical strategies for companies to navigate and thrive in the current funding environment
• How has the rise of China as a life science powerhouse reshaped the global investment patterns, and where does the US and Europe stand in comparison?

• Exploring why private companies are dominating the M&A landscape and how this trend is reshaping biopharma exit strategies
• Practical steps to make your company an attractive target, from building a compelling pipeline to demonstrating market readiness
• Insights into how to navigate mergers and acquisitions, including deal structuring, negotiations, and integration planning
• Key factors driving decisions between acquiring individual assets versus entire pipelines, and how companies can align their strategy with buyer priorities

• Status of the US IPO Market – Transactions that are closing
• IPO Readiness Check – Key financial, operational, structural, and leadership elements you need in place.
• Valuation & Funding Needs – How to determine your worth and secure the right amount of capital.
• Why & How to Go Public – Understanding the motivations, risks, and different pathways (IPO, RTO, SPAC, direct listing).
• Avoiding Pitfalls – Common challenges biotech companies face and how to navigate them.
• IPO Process – Financial Requirements, Listing Requirements, Legal Filings

• Which markets are currently most desirable for startups and why?
• Navigating varied and complex regulatory requirements across China, Europe, and the Middle East
• Discussing the importance of forming local alliances and strategic collaboration partners
• Tailoring your business and commercialization plans to fit the unique dynamics of each regional market
• Understanding how to safeguard your intellectual property and comply with regional data privacy laws while expanding your global footprint

• Overview of the growth we’ve seen in the space in recent years
• Highlighting breakthroughs in diagnostics, therapeutics, and digital health solutions tailored to women’s needs
• Understand how investors are shifting focus toward women’s health and what it means for startups
• Discussing how low reimbursement rates affect women's health and what needs to be done to fix this
• A look at home advancing women's brain health is a strategic pathway to strengthening global brain care

• Strategies for securing investment in a competitive and evolving market
• Discussing the key metrics that define viability and ROI in TechBio
• Identify what sets strong TechBio companies apart from short-lived trends
• Examine the long-term potential of TechBio as a profitable business model
• Gain insights into what investors prioritize when evaluating TechBio opportunities

• How to adapt exit strategies in a cautious and unpredictable financial landscape
• Beyond the IPO - exploring alternative pathways to liquidity that are gaining traction in today’s market
• Advice from industry leaders on mastering your exit strategy in a shifting environment
• How to be “exit ready” at all times by maintaining strong financials, a clear growth narrative, and a well-defined plan for providing a return to stakeholders

As life sciences evolve, corporate venture capital (CVC) is becoming a critical driver of innovation. With big pharma and tier 1 medtechs shifting focus from internal R&D to external innovation, CVCs are playing a pivotal role in identifying and funding transformative solutions. This panel brings together CVC leaders to share insights into their investment strategies, decision-making processes, and how startups can successfully engage with these global giants

• How do CVC’s balance strategic goals with financial returns?
• Understand the focus areas and key factors that guide CVC decision-making
• Building strong, mutually beneficial relationships with CVCs